(Reuters) – China’s Sinovac Biotech said on Saturday that South Africa’s health products regulator has granted conditional registration to its coronavirus vaccine CoronaVac for people aged 18 and above.
(Reporting by Akanksha Khushi in Bengaluru; Editing by Sam Holmes)